Cholesterol Monitors Market Insights, Outlook, Development and Trends 2022-2032

In 2022, it is anticipated that the Cholesterol Monitors Market is valued US$ 2,514.6 million. The cholesterol monitors market is expected to expand at a 7.4% CAGR from 2022 to 2032 and is likely generate US$ 4,502.4 million.

Rising rates of obesity and an aging population in developed nations like the U.S., Germany, and France have increased the cases of patients with high levels of bad cholesterol, necessitating a daily rise in the need for cholesterol monitoring kits worldwide.

The global market for cholesterol monitors is likely to expand due to the rising popularity of non-invasive technologies for cholesterol monitoring.

What are the Factors Propelling the Global Cholesterol Monitors Market?

The increasing prevalence of cardiovascular disorders, coupled with a growing emphasis on early diagnosis and miniaturization of cholesterol monitors, is expected to drive the growth of the global cholesterol monitor market. The preference for self-monitoring to enhance quality of life and lead a healthy lifestyle is another factor driving the expansion of the global market for cholesterol monitors.

Additionally, the market is likely to expand due to the increased focus on reducing the burden of cardiovascular diseases (CVDs) around the world, as well as initiatives for preventive healthcare practices like screening and health check-up programs.

The development of the global cholesterol monitor market is also aided by governmental changes that provide state-of-the-art healthcare facilities and awareness campaigns that are likely to raise the standard of testing.

Why is North America Emerging as an Opportunistic Cholesterol Monitors Market?

North America dominates the global cholesterol monitors market, accounting for nearly 35% in 2022. This market growth is primarily due to the rise in the incidence of CVDs, coupled with the rapidly aging population, high preference for self-monitoring devices, and increased awareness related to prevention and early diagnosis of the diseases in the region.

According to the Centers for Disease Control and Prevention, nearly 1 in 2 Americans have high cholesterol i.e., nearly 38% of American adults have high cholesterol (total blood cholesterol ≥ 200 mg/dL).1 Too much cholesterol puts you at risk for heart disease and stroke, two leading causes of death in the United States.

Owing to the increased risk of high cholesterol and its asymptomatic nature, the need for cholesterol monitors is burgeoning incessantly in the region. Additionally, the prevalence of heart diseases and obesity in the region is a major concern.

The United Health Foundation’s annual report revealed that the obesity rate increased from 31.5% in 2021 to 30.4% in 2020 in the United States. This, in turn, the mounting preference for preventive healthcare is also anticipated to drive regional growth. Rising awareness and initiatives from the government and several healthcare organizations are expected to propel market growth.

Key Players

  • Roche Diagnostics
  • PTS Diagnostics
  • Omron Healthcare, Inc.
  • ACON Laboratories, Inc.
  • AccuTech
  • LLC
  • Alere Inc.
  • Siemens
  • Medline Industries, Inc.
  • Abaxis, Inc.
  • ManthaMed
  • Fisher Scientific

Segments Covered

  • Product Type
  • End User

Key Segments Covered in the Cholesterol Monitors Industry Survey

By Product Type:

  • Single-sided COD Chip-On-Flex
  • Other Chip-On-Flex Types

By End Users:

  • Military
  • Medical
  • Aerospace
  • Electronics
  • Other Verticals

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Japan
  • Middle East and Africa

Read More @ https://www.futuremarketinsights.com/reports/cholesterol-monitors-market

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more